ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,832 | -29.5% | 87,584 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $121,741 | -12.6% | 87,584 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $139,258 | -74.4% | 87,584 | +0.2% | 0.00% | -66.7% |
| Q4 2022 | $544,402 | -44.0% | 87,384 | -39.8% | 0.01% | -40.0% |
| Q3 2022 | $973,000 | -12.8% | 145,245 | -17.3% | 0.01% | -9.1% |
| Q2 2022 | $1,116,000 | +32.5% | 175,669 | -3.3% | 0.01% | +37.5% |
| Q1 2022 | $842,000 | +10.2% | 181,701 | +18.8% | 0.01% | +14.3% |
| Q4 2021 | $764,000 | -46.0% | 152,932 | +30.2% | 0.01% | -41.7% |
| Q3 2021 | $1,415,000 | -12.2% | 117,500 | +54.2% | 0.01% | 0.0% |
| Q2 2021 | $1,611,000 | +4781.8% | 76,200 | +6250.0% | 0.01% | – |
| Q1 2021 | $33,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $99,609,000 | 22.32% |
| Bellevue Group AG | 5,465,715 | $203,160,000 | 2.81% |
| Rhenman & Partners Asset Management AB | 455,000 | $16,912,000 | 1.50% |
| Endurant Capital Management LP | 135,901 | $5,051,000 | 1.49% |
| Boxer Capital, LLC | 975,000 | $36,241,000 | 1.25% |
| DCF Advisers, LLC | 56,500 | $2,100,000 | 1.07% |
| Pentwater Capital Management LP | 2,169,022 | $80,623,000 | 1.04% |
| Nicholas Investment Partners, LP | 235,855 | $8,767,000 | 0.95% |
| Amia Capital LLP | 20,464 | $761,000 | 0.88% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,717,000 | 0.83% |